A. Craig Lockhart

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, Khaldoun Almhanna et al. · Journal of the National Comprehensive Cancer Network · 2016 · 940 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +13

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 752 citations · Full text

Tumor Biology, Oncology, Medicine +8

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Timothy M. Nywening, Andrea Wang‐Gillam, Dominic E. Sanford et al. · The Lancet Oncology · 2016 · 746 citations · Full text

Pancreatic Cancer, Tumour-associated Macrophages, Medicine +8

Esophageal and Esophagogastric Junction Cancers, Version 1.2015

Jaffer A. Ajani, Thomas A. D’Amico, Khaldoun Almhanna et al. · Journal of the National Comprehensive Cancer Network · 2015 · 652 citations · Full text

Surgical Oncology, Esophagus, Esophageal Cancer +15

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

Manish A. Shah, Takashi Kojima, Daniel Hochhauser et al. · JAMA Oncology · 2018 · 511 citations · Full text